Unimarck Pharma (India) Limited - Company Profile

It is a pharma public limited company based in Chandigarh, Chandigarh, India, established in 1984.
1984 Chandigarh, Chandigarh, India Active
Last Updated:
Access Report
About Unimarck Pharma (India) Limited

Unimarck Pharma (India) Limited, a active public limited company, was established on 12 March 1984 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232CH1984PLC005768. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.79 Cr.

Formerly known as Unimarck Pharma Private Limited. It upholds a compliant status. Employing 409 professional, Its leadership includes Gagandeep Bhatia (Whole-Time Director), Harleen Kaur Bhatia (Director), Harsh Bhatia (Whole-Time Director). Past directors included Gagandeep Bhatia, Judgebir Singh Ahluwalia, Sukhbir Singh Nayar. It holds ₹21.65 Cr open charges and ₹37.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sco 56 & 57, Next To Gpo, Shopping Plaza 17D, Sector 17, Chandigarh, Chandigarh, 160017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232CH1984PLC005768

  • Registration Number

    005768

  • Incorporation Date

    12 March 1984

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.79 Cr

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.79 Cr
  • Company Age 41 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 21.65 Cr
  • Satisfied Charges ₹ 37.00 Cr
  • Revenue Growth **** -16.96%
  • Profit Growth **** -30.12%
  • Ebitda **** -40.07%
  • Net Worth -8.16%
  • Total Assets **** 2.70%
Company report

Unimarck Pharma (India) Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unimarck Pharma (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Unimarck Pharma (India) Limited?
Current Directors
Name Designation Appointment Date Status
Gagandeep Bhatia Whole-Time Director 10 Aug 2000 Current
Harleen Kaur Bhatia Director 01 Apr 2023 Current
Harsh Bhatia Whole-Time Director 12 Mar 1984 Current
Mandeep Singh Managing Director 03 Dec 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2010 Past
Pramod Abcsdd Additional Director 29 Sep 2007 Past
Pramod Abcsdd Director 06 Jul 2009 Past
Pramod Abcsdd Director 06 Jul 2009 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Whole-Time Director 15 Feb 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unimarck Pharma (India).

Unimarck Pharma (India) Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 16.96% decrease. The company also saw a substantial fall in profitability, with a 30.12% decrease in profit. The company's net worth dipped by a decrease of 8.16%.

Unimarck Pharma (India) revenue growth over time
Unimarck Pharma (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -16.96%
*******
*******
*******
*******
Revenue from Operations
*******
 -17.53%
*******
*******
*******
*******
Total Assets
*******
 2.70%
*******
*******
*******
*******
Profit or Loss
*******
 -30.12%
*******
*******
*******
*******
Net Worth
*******
 -8.16%
*******
*******
*******
*******
EBITDA
*******
 -40.07%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unimarck Pharma (India)?

In 2024, Unimarck Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹216,540,000.00

Satisfied Charges

₹369,954,000.00

Charges Breakdown by Lending Institutions
  • Others : 21.65 Cr
Latest Charge Details
Date Lender Amount Status
01 Jul 2023 Others ₹1.59 M Open
10 May 2017 Others ₹13.26 Cr Open
17 Jul 1993 Others ₹8.24 Cr Open
10 Sep 2021 Hdfc Bank Limited ₹8.50 M Satisfied
17 Apr 2015 Punjab National Bank ₹2.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Unimarck Pharma (India)?

Unimarck Pharma (India) has a workforce of 409 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unimarck Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimarck Pharma (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unimarck Pharma (India)
Recent Activity within the Organization
  • Annual General Meeting

    The activity Unimarck Pharma (India) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Unimarck Pharma (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was documented.

  • Charges

    Progress on A charge registered on 10 Sep 2021 via Charge ID 100485631 with Hdfc Bank Limited was fully satisfied on 08 Dec 2024. was documented.

  • Charges

    A charge with Others amounted to Rs. 0.16 Cr with Charge ID 100741152 was registered on 01 Jul 2023. was recorded as a recent event.

  • Director Appointment

    The activity Harleen Kaur Bhatia was appointed as a Director was appointed as a Director on 01 Apr 2023 & has been associated with this company since 2 years 10 months . was completed.

  • Charges

    A charge with Others of Rs. 13.26 Cr registered on 10 May 2017 with Charge ID 100099413 was modified on 19 May 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Unimarck Pharma (India) Limited?

The CIN of Unimarck Pharma (India) Limited is U24232CH1984PLC005768.

Where is Unimarck Pharma (India) Limited headquartered?

Unimarck Pharma (India) Limited is headquartered at Sco 56 & 57, Next To Gpo, Shopping Plaza 17D, Sector 17, Chandigarh, Chandigarh, 160017.

When was Unimarck Pharma (India) Limited incorporated?

Unimarck Pharma (India) Limited was incorporated on 12 March 1984.

Who are the current directors of Unimarck Pharma (India) Limited?

The current directors of Unimarck Pharma (India) Limited are

What is the primary industry of Unimarck Pharma (India) Limited?

The primary industry of Unimarck Pharma (India) Limited is Manufacturing.

Is Unimarck Pharma (India) Limited a listed company?

Unimarck Pharma (India) Limited is unlisted.

What is the capital structure of Unimarck Pharma (India) Limited?

The authorized capital of Unimarck Pharma (India) Limited is ₹2.00 Cr, and the paid-up capital is ₹1.79 Cr.

What is the compliance status of Unimarck Pharma (India) Limited?

The compliance status of Unimarck Pharma (India) Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available